Burning Rock Biotech Ltd (BNR)vsNatera Inc (NTRA)
BNR
Burning Rock Biotech Ltd
$12.18
+2.61%
HEALTHCARE · Cap: $129.62M
NTRA
Natera Inc
$424.42
+3.31%
HEALTHCARE · Cap: $58.35B
Smart Verdict
WallStSmart Research — data-driven comparison
Natera Inc generates 441% more annual revenue ($2.71B vs $500.64M). NTRA leads profitability with a -7.1% profit margin vs -13.6%. NTRA earns a higher WallStSmart Score of 31/100 (F).
BNR
Avoid29
out of 100
Grade: F
NTRA
Avoid31
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Conservative balance sheet, low leverage
Reasonable price relative to book value
Revenue surging 37.7% year-over-year
Large-cap with strong market position
Conservative balance sheet, low leverage
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
ROE of -10.7% — below average capital efficiency
Revenue declined 9.3%
0.0% earnings growth
Weak financial health signals
Trading at 33.5x book value
ROE of -10.6% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : BNR
The strongest argument for BNR centers on Debt/Equity, Price/Book.
Bull Case : NTRA
The strongest argument for NTRA centers on Revenue Growth, Market Cap, Debt/Equity. Revenue growth of 37.7% demonstrates continued momentum.
Bear Case : BNR
The primary concerns for BNR are EPS Growth, Market Cap, Return on Equity.
Bear Case : NTRA
The primary concerns for NTRA are EPS Growth, Piotroski F-Score, Price/Book.
Key Dynamics to Monitor
BNR profiles as a turnaround stock while NTRA is a hypergrowth play — different risk/reward profiles.
NTRA carries more volatility with a beta of 1.50 — expect wider price swings.
NTRA is growing revenue faster at 37.7% — sustainability is the question.
NTRA generates stronger free cash flow (-9M), providing more financial flexibility.
Bottom Line
NTRA scores higher overall (31/100 vs 29/100) and 37.7% revenue growth. Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Burning Rock Biotech Ltd
HEALTHCARE · DIAGNOSTICS & RESEARCH · China
Burning Rock Biotech Limited primarily develops and provides screening tests for cancer therapies in the People's Republic of China. The company is headquartered in Guangzhou, China.
Natera Inc
HEALTHCARE · DIAGNOSTICS & RESEARCH · USA
Natera, Inc., a diagnostic company, develops and markets molecular testing services globally. The company is headquartered in San Carlos, California.
Compare with Other DIAGNOSTICS & RESEARCH Stocks
Want to dig deeper into these stocks?